CD13-A key player in multi-drug resistance in cancer chemotherapy.

CD13-A key player in multi-drug resistance in cancer chemotherapy. Oncol Res. 2020 Jun 12;: Authors: Guo Q, Li X, Cui MN, Sun JL, Ji HY, Ni BB, Yan MX Abstract Cancer is one of the most serious diseases that are harmful to human health. Systemicchemotherapy is an optimal therapeutic strategy for the treatment of cancer, but greatdifficulty has been encountered in its administration in the form of multidrug resistance(MDR). As an enzyme on the outer cell surface, CD13 is documented to be involved inthe MDR development of tumor cells. In this review, we will focus on the role of CD13in MDR generation based on the current evidence. PMID: 32532363 [PubMed - as supplied by publisher]
Source: Oncology Research - Category: Cancer & Oncology Tags: Oncol Res Source Type: research